Literature DB >> 14140000

EFFECT OF DOSAGE FORM PROPERTIES ON THERAPEUTIC EFFICACY OF TOLBUTAMIDE TABLETS.

G LEVY.   

Abstract

The rate of gastrointestinal absorption and the physiologic availability of tolbutamide are functions of the dissolution rate of the drug in gastrointestinal fluids. This property can be modified markedly by pharmaceutical formulation factors. The in vitro dissolution rates of clinically efficacious and clinically inefficacious tolbutamide tablets have been determined, and it has been found that the former dissolved considerably more rapidly than the latter. Once diabetic patients have been "titrated" with a particular brand of tolbutamide they should not be switched to a different brand without "retitration." There is need to establish an adequate in vitro test to assure the physiologic availability of tolbutamide from commercial tablets.

Entities:  

Keywords:  ABSORPTION; CHEMISTRY, PHARMACEUTICAL; EXPERIMENTAL LAB STUDY; GASTROINTESTINAL SYSTEM; TABLETS; TOLBUTAMIDE

Mesh:

Substances:

Year:  1964        PMID: 14140000      PMCID: PMC1922626     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  6 in total

1.  EFFECT OF CERTAIN TABLET FORMULATION FACTORS ON DISSOLUTION RATE OF THE ACTIVE INGREDIENT. I. IMPORTANCE OF USING APPROPRIATE AGITATION INTENSITIES FOR IN VITRO DISSOLUTION RATE MEASUREMENTS TO REFLECT IN VIVO CONDITIONS.

Authors:  G LEVY
Journal:  J Pharm Sci       Date:  1963-11       Impact factor: 3.534

2.  EFFECT OF CERTAIN TABLET FORMULATION FACTORS ON DISSOLUTION RATE OF THE ACTIVE INGREDIENT. II. GRANULE SIZE, STARCH CONCENTRATION, AND COMPRESSION PRESSURE.

Authors:  G LEVY; J M ANTKOWIAK; J A PROCKNAL; D C WHITE
Journal:  J Pharm Sci       Date:  1963-11       Impact factor: 3.534

3.  The effect of dosage form upon the gastrointestinal absorption rate of salicylates.

Authors:  G LEVY; R H GUMTOW; J M RUTOWSKI
Journal:  Can Med Assoc J       Date:  1961-08-19       Impact factor: 8.262

4.  Comparison of dissolution and absorption rates of different commercial aspirin tablets.

Authors:  G LEVY
Journal:  J Pharm Sci       Date:  1961-05       Impact factor: 3.534

5.  Physicochemical basis of the buffered acetylsalicylic acid controversy.

Authors:  G LEVY; B A HAYES
Journal:  N Engl J Med       Date:  1960-05-26       Impact factor: 91.245

6.  Substitution for Brand-Name Drugs.

Authors:  S Caminetsky
Journal:  Can Med Assoc J       Date:  1963-05-04       Impact factor: 8.262

  6 in total
  1 in total

1.  Serum concentrations and bioavailability of rifampicin and isoniazid in combination.

Authors:  J C Garnham; T Taylor; P Turner; L F Chasseaud
Journal:  Br J Clin Pharmacol       Date:  1976-10       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.